How The Pandemic Has Accelerated Collaboration: A CDMO Perspective

The SARS-CoV-2 pandemic has accelerated unique global collaboration between academia, government, biotech, pharma, and the manufacturing industry, leading to scientific breakthroughs and advanced medicines being produced at unprecedented speed. How has this been possible, and what can we learn from our experiences? In this webinar, contract development and manufacturing organization Cobra Biologics, now a Charles River company, is joined by special guests to discuss.

Discussion points:

• CHALLENGES – Hurdles from a CDMO, drug developer, and supplier perspective
• IMPACT – Evolving approaches to collaboration and in turn, drug production
• LEARNINGS – Applying acquired knowledge and collaborative frameworks to the real world